GENE ONLINE|News &
Opinion
Blog

Monoclonal Antibody
GEN-001
Korean Firm, Asia’s First to Get FDA Clearance for Testing Anti-Cancer Microbiome Therapeutic
2020-04-24
Allergic Asthma
LEO Pharma Strikes Deal with Asian Firms to Develop Atopic Dermatitis & Allergic Asthma Drug
2020-04-17
Trials & Approvals Anti-PD-1
Beigene’s Tislelizumab-Chemo Combo Nails Primary Endpoint in Phase 3 Trial
2020-04-16
Trials & Approvals
GSK Reports Positive Results for Nucala in Patients with Nasal Polyps
2020-04-05
R&D PD-L1
Roche Identifies Biomarker that Determines Patient Response to Immunotherapy
2020-03-15
COVID-19
Vir Biotechnology Stocks Raise after COVID-19 Partnership with Biogen
2020-03-12
COVID-19 RT-PCR
Rapid Diagnosis: Academia Sinica’s New COVID-19 Detection Kit Augurs well for Combating the Epidemic
2020-03-10
M&A CD47
Gilead Strikes US$ 4.9B Takeover Deal of Forty Seven
2020-03-02
TJM2
Weekly in Asia｜Nov-1
2019-11-19
Trials & Approvals Breast Cancer
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
Ranking & Reports Cancer
Weekly Top 5 in China (0224-0302)
2019-03-11
Trials & Approvals Breast Cancer
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
Ranking & Reports
Weekly Top 5 in China (0127-0202)
2019-01-29
Trials & Approvals Antibody
Tecentriq bags yet another FDA approval, this time as a combo therapy for NSCLC
2018-12-24
Trials & Approvals Autoimmune
Novartis’s Ligelizumab Progresses to Phase III Trial
2018-12-17
1 … 3 4 5 6
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top